59 Episoade

  1. Holy poop! Mental health and the gut (part 2 with Bloom Science)

    Publicat: 28.09.2023
  2. Holy poop! Mental health and the gut (part 1 with Holobiome)

    Publicat: 14.09.2023
  3. Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)

    Publicat: 24.08.2023
  4. Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)

    Publicat: 17.08.2023
  5. The Startup Landscape for Expanding Consciousness

    Publicat: 09.08.2023
  6. Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)

    Publicat: 20.07.2023
  7. Live from Psychedelic Science 2023

    Publicat: 07.07.2023
  8. What VCs Look for in Psychedelic Companies

    Publicat: 09.06.2023
  9. Developing Non-Hallucinogenic Psychedelics: Bryan Roth

    Publicat: 15.05.2023
  10. Behind the Scenes of PsyMed Ventures

    Publicat: 14.04.2023
  11. The 2023 Psychedelic Industry Landscape with Psychedelic Alpha

    Publicat: 27.02.2023
  12. The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)

    Publicat: 18.01.2023
  13. The quest to improve MDMA

    Publicat: 20.12.2022
  14. Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment

    Publicat: 29.11.2022
  15. Perspectives from Christian Angermayer, investor and founder in psychedelics

    Publicat: 27.10.2022
  16. Soltara: an ethical and profitable ayahuasca retreat

    Publicat: 14.09.2022
  17. Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics

    Publicat: 16.08.2022
  18. Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti

    Publicat: 10.08.2022
  19. Microdosing (part 1): James Fadiman and the fundamentals of microdosing

    Publicat: 03.08.2022
  20. How the DEA and FDA will regulate psychedelic medicine

    Publicat: 24.06.2022

2 / 3

Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more. 

Visit the podcast's native language site